1.This Act may be cited as the
Combat Meth Act of
2005
.
<enum>I</enum><header>Enforcement</header>
<section changed="deleted" id="idC33388E8AB724D9EA809C2DC2FF15653" reported-display-style="strikethrough"><enum>101.</enum><header>Authorization
of appropriations relating to COPS grants</header>
<subsection changed="deleted" id="idEDA1ED13E26D452DABDB734879793F1B" reported-display-style="strikethrough"><enum>(a)</enum><header>In
general</header><text>In addition to any other funds authorized to be
appropriated for fiscal year 2006 for grants under part Q of title I of the
<act-name parsable-cite="OCCSS">Omnibus Crime Control and Safe Streets Act of
1968</act-name> (<external-xref legal-doc="usc" parsable-cite="usc/42/3796dd">42 U.S.C. 3796dd</external-xref> et seq.),
commonly known as the COPS program, there are authorized to be appropriated
$15,000,000 for such purpose to provide training to State and local prosecutors
and law enforcement agents for the investigation and prosecution of
methamphetamine offenses.</text>
</subsection><subsection changed="deleted" id="id48772B6D5FCC4F40B31BBACF8774F8FD" reported-display-style="strikethrough"><enum>(b)</enum><header>Rural
Set-Aside</header><text>Of amounts made available under subsection (a),
$3,000,000 shall be available only for prosecutors and law enforcement agents
for rural communities.</text>
</subsection></section><section changed="deleted" id="ID31F907DB2F0F42E6B78DBF7FEA7DA705" reported-display-style="strikethrough"><enum>102.</enum><header>Expansion of
methamphetamine hot spots program to include personnel and equipment for
enforcement, prosecution, and cleanup</header><text display-inline="no-display-inline">Section 1701(d) of the
<act-name parsable-cite="OCCSS">Omnibus Crime Control and Safe Streets Act of
1968</act-name> (<external-xref legal-doc="usc" parsable-cite="usc/42/3796dd(d)">42 U.S.C. 3796dd(d)</external-xref>) is
amended—</text>
<paragraph changed="deleted" id="IDF473B5D3B27040C089512161CFB8A4A5" reported-display-style="strikethrough"><enum>(1)</enum><text>in paragraph (11)
by striking <quote>and</quote> at the end;</text>
</paragraph><paragraph changed="deleted" id="IDEA1E3BAC6B444C59BE07448437F29A18" reported-display-style="strikethrough"><enum>(2)</enum><text>in paragraph (12)
by striking the period at the end and inserting <quote>; and</quote>;
and</text>
</paragraph><paragraph changed="deleted" id="IDF33A5C85ED1F47F2B32FDC13FF64B7A2" reported-display-style="strikethrough"><enum>(3)</enum><text>by adding at the
end the following:</text>
<quoted-block changed="deleted" display-inline="no-display-inline" id="ID6EDF43F9BE504EAA92B7CE60E880964E" reported-display-style="strikethrough" style="OLC">
<paragraph changed="deleted" commented="no" id="ID7F42AC931F7B4565BFAFBC20AC61B345" reported-display-style="strikethrough"><enum>(13)</enum><text>hire personnel
and purchase equipment to assist in the enforcement and prosecution of
methamphetamine offenses and the cleanup of methamphetamine-affected
areas.</text>
</paragraph><after-quoted-block>.</after-quoted-block></quoted-block>
</paragraph></section><section changed="deleted" commented="no" id="id0BE16ABCCC454C659BB708C8B78690BA" reported-display-style="strikethrough"><enum>103.</enum><header>Special United
States attorneys' program</header>
<subsection changed="deleted" commented="no" id="idB9952753C5A842EBB30DC17D8E0E9151" reported-display-style="strikethrough"><enum>(a)</enum><header>In
general</header><text>The Attorney General shall allocate any amounts
appropriated pursuant to the authorization under subsection (c) for the hiring
and training of special assistant United States attorneys.</text>
</subsection><subsection changed="deleted" commented="no" id="id66BBC300800C4842BCBC35EB620396FC" reported-display-style="strikethrough"><enum>(b)</enum><header>Use of
funds</header><text>The funds allocated under subsection (a) shall be used
to—</text>
<paragraph changed="deleted" commented="no" id="idF0723A81700B4680922C0712982D5693" reported-display-style="strikethrough"><enum>(1)</enum><text>train local
prosecutors in techniques used to prosecute methamphetamine cases, including
the presentation of evidence related to the manufacture of
methamphetamine;</text>
</paragraph><paragraph changed="deleted" commented="no" id="id0DA9A55B628B40D09186DB5AF3ABD4CE" reported-display-style="strikethrough"><enum>(2)</enum><text>train local
prosecutors in Federal and State laws involving methamphetamine manufacture or
distribution;</text>
</paragraph><paragraph changed="deleted" commented="no" id="id975167F0EDDA42A2AC8C7DAB366D177C" reported-display-style="strikethrough"><enum>(3)</enum><text>cross-designate
local prosecutors as special assistant United States attorneys; and</text>
</paragraph><paragraph changed="deleted" commented="no" id="idC1A4C51884F34DC787944FCD188F985C" reported-display-style="strikethrough"><enum>(4)</enum><text>hire additional
local prosecutors who—</text>
<subparagraph changed="deleted" commented="no" id="id61F3668C7BD54ECA9F9E35DB47D2EA11" reported-display-style="strikethrough"><enum>(A)</enum><text>with the approval
of the United States attorney, shall be cross-designated to prosecute both
Federal and State methamphetamine cases;</text>
</subparagraph><subparagraph changed="deleted" commented="no" id="id1EDAC9B83914469B85677FBD603B0FCC" reported-display-style="strikethrough"><enum>(B)</enum><text>shall be assigned
a caseload, whether in State court or Federal court, that gives the highest
priority to cases in which—</text>
<clause changed="deleted" commented="no" id="id202509C98EB049B5B5E983A3C71CB168" reported-display-style="strikethrough"><enum>(i)</enum><text>charges related to
methamphetamine manufacture or distribution are submitted by law enforcement
for consideration; and</text>
</clause><clause changed="deleted" commented="no" id="id91432CAE0A204465871E6CEF18C91135" reported-display-style="strikethrough"><enum>(ii)</enum><text>the defendant has
been previously convicted of a crime related to methamphetamine manufacture or
distribution.</text>
</clause></subparagraph></paragraph></subsection><subsection changed="deleted" commented="no" id="id6076637CB03145C28FC79F275190B5FC" reported-display-style="strikethrough"><enum>(c)</enum><header>Authorization of
appropriations</header><text>There are authorized to be appropriated $5,000,000
for each of the fiscal years 2006 and 2007 to carry out the provisions of this
section.</text>
</subsection></section><section changed="deleted" commented="no" id="id9CC84D9493414B4CB324297568FA1265" reported-display-style="strikethrough"><enum>104.</enum><header>Pseudoephedrine
amendments to Controlled Substances Act</header>
<subsection changed="deleted" commented="no" id="id63AA9573081E44F8A3918770492DA2DA" reported-display-style="strikethrough"><enum>(a)</enum><header>Addition of
pseudoephedrine to schedule V</header><text>Section 202 of the Controlled
Substances Act (21 U.S.C. 812) is amended by adding at the end the
following:</text>
<quoted-block changed="deleted" display-inline="no-display-inline" id="id609447A87AC84BB09863E62B9AE05BE9" reported-display-style="strikethrough" style="OLC">
<paragraph changed="deleted" commented="no" id="idC9D834EAE43D4C85A9443C9AC552CC90" reported-display-style="strikethrough"><enum>(6)</enum><text>Any detectable
quantity of pseudoephedrine, its salts or optical isomers, or salts of optical
isomers.</text>
</paragraph><after-quoted-block>.</after-quoted-block></quoted-block>
</subsection><subsection changed="deleted" commented="no" id="id7D49C57F9787421FB4FEA13AC061ADF6" reported-display-style="strikethrough"><enum>(b)</enum><header>Prescriptions</header><text>Section
309(c) of the Controlled Substances Act (21 U.S.C. 829(c)) is amended—</text>
<paragraph changed="deleted" commented="no" id="id47479DEEBADC4DADBFBB55C7E8EF4780" reported-display-style="strikethrough"><enum>(1)</enum><text>by inserting
<quote>(1)</quote> before <quote>No controlled substance</quote>; and</text>
</paragraph><paragraph changed="deleted" commented="no" id="id2D48B84E57144F3F8D43B931793E102A" reported-display-style="strikethrough"><enum>(2)</enum><text>by adding at the
end the following:</text>
<quoted-block changed="deleted" display-inline="no-display-inline" id="id12D0B5C86C704A7A9DFEAE510412FC08" reported-display-style="strikethrough" style="OLC">
<paragraph changed="deleted" commented="no" id="idE86C545DF6BC437ABA3FD40C7F507374" indent="up1" reported-display-style="strikethrough"><enum>(2)</enum><text>If the substance
described in paragraph (6) of Schedule V of section 202 is dispensed, sold, or
distributed in a pharmacy—</text>
<subparagraph changed="deleted" commented="no" id="idDD540F7EDD40455AB80D16DE9B50B30B" reported-display-style="strikethrough"><enum>(A)</enum><text>the substance
shall be dispensed, sold, or distributed only by a licensed pharmacist or a
licensed pharmacy technician; and</text>
</subparagraph><subparagraph changed="deleted" commented="no" id="id9777B3794CA6423E86B3CF52F42645F3" reported-display-style="strikethrough"><enum>(B)</enum><text>any person
purchasing, receiving, or otherwise acquiring any such substance shall—</text>
<clause changed="deleted" commented="no" id="idF69BF0175B974BE2B480340A7ED26401" reported-display-style="strikethrough"><enum>(i)</enum><text>produce a photo
identification showing the date of birth of such person; and</text>
</clause><clause changed="deleted" commented="no" id="idF4CC0977029C485B875B7D7659C23971" reported-display-style="strikethrough"><enum>(ii)</enum><text>sign a written
log or receipt showing—</text>
<subclause changed="deleted" commented="no" id="id2D8FA5ACCBDF4BE7AAF51C5BB9397A2E" reported-display-style="strikethrough"><enum>(I)</enum><text>the date of the
transaction;</text>
</subclause><subclause changed="deleted" commented="no" id="id43D79E4598744E0E9184A7DEFE0309D5" reported-display-style="strikethrough"><enum>(II)</enum><text>the name of the
person; and</text>
</subclause><subclause changed="deleted" commented="no" id="idC8C45C8ACA1B4BA182DFBFDAC4233D28" reported-display-style="strikethrough"><enum>(III)</enum><text>the name and the
amount of the substance purchased, received, or otherwise acquired.</text>
</subclause></clause></subparagraph></paragraph><paragraph changed="deleted" commented="no" id="idBF7124970FD5480BA9F0129D8274F0E5" indent="up1" reported-display-style="strikethrough"><enum>(3)</enum><subparagraph commented="no" display-inline="yes-display-inline" id="id8CE4D5C627B74CFB96A8C6C3C0536A0A"><enum>(A)</enum><text>No person shall
purchase, receive, or otherwise acquire more than 9 grams of the substance
described in paragraph (6) of Schedule V of section 202 within any 30-day
period.</text>
</subparagraph><subparagraph changed="deleted" commented="no" id="id7CA97F1BEF6A4BABA7FEA4310855E06B" indent="up1" reported-display-style="strikethrough"><enum>(B)</enum><text>The limit
described in subparagraph (A) shall not apply to any quantity of such substance
dispensed under a valid prescription.</text>
</subparagraph></paragraph><paragraph changed="deleted" commented="no" id="id8FE969B8668F45BBAB5AAE84EB89E321" indent="up1" reported-display-style="strikethrough"><enum>(4)</enum><subparagraph commented="no" display-inline="yes-display-inline" id="id1FC1B7141B544D3390C663D287A2EA82"><enum>(A)</enum><text>The Director of the
Federal Drug Administration, by rule, may exempt a product from Schedule V of
section 202 if the Director determines that the produce is not used in the
illegal manufacture of methamphetamine or other controlled dangerous
substance.</text>
</subparagraph><subparagraph changed="deleted" commented="no" id="id3AAD0706618A4849995E87F4BD695838" indent="up1" reported-display-style="strikethrough"><enum>(B)</enum><text>The Director of
the Federal Drug Administration, upon the application of a manufacturer of a
drug product, may exempt the product from Schedule V of section 202 if the
Director determines that the product has been formulated in such a way as to
effectively prevent the conversion of the active ingredient into
methamphetamine.</text>
</subparagraph><subparagraph changed="deleted" commented="no" id="id029FE7A63C3A46858A0678D02F479D12" indent="up1" reported-display-style="strikethrough"><enum>(C)</enum><text>The Director of
the Federal Drug Administration, by rule, may authorize the sale of the
substance described in paragraph (6) of Schedule V of section 202 by persons
other than licensed pharmacists or licensed pharmacy technicians if—</text>
<clause changed="deleted" commented="no" id="id97CFAE29151D4ED689E97DC67A8D131F" reported-display-style="strikethrough"><enum>(i)</enum><text>the Director finds
evidence that the absence of a pharmacy creates a hardship for a community;
and</text>
</clause><clause changed="deleted" commented="no" id="id3FCDF01F4BD148E4BC407F0EE5CCA009" reported-display-style="strikethrough"><enum>(ii)</enum><text>the authorized
personnel follow the procedure set forth in this
Act.</text>
</clause></subparagraph></paragraph><after-quoted-block>.</after-quoted-block></quoted-block>
</paragraph></subsection></section><enum>II</enum><header>Education,
prevention, and treatment</header>
<section changed="deleted" id="id06DACF05E5CE4A0FA1A01164E73F634B" reported-display-style="strikethrough"><enum>201.</enum><header>Grants for
services for children of substance abusers</header><text display-inline="no-display-inline">Section 519 of the Public Health Service Act
(42 U.S.C. 290bb–25) is amended—</text>
<paragraph changed="deleted" id="id15136370BE1040EE912BFAAAFF80BBCB" reported-display-style="strikethrough"><enum>(1)</enum><text display-inline="yes-display-inline">in subsection (b), by inserting after
paragraph (8) the following:</text>
<quoted-block changed="deleted" display-inline="no-display-inline" id="id63B1A6F16EF44BBDA3CB2C9395875047" reported-display-style="strikethrough" style="OLC">
<paragraph changed="deleted" id="id934D7CE2514B4516B8186A0D21DEBB03" reported-display-style="strikethrough"><enum>(9)</enum><text>Development of
drug endangered children rapid response teams that will intervene on behalf of
children exposed to methamphetamine as a result of residing or being present in
a home-based clandestine drug
laboratory.</text>
</paragraph><after-quoted-block>;
and</after-quoted-block></quoted-block>
</paragraph><paragraph changed="deleted" id="idAE2C666DF8B5405C8CED6F0C1593343A" reported-display-style="strikethrough"><enum>(2)</enum><text>in subsection
(o)—</text>
<subparagraph changed="deleted" id="id9AE934B10C3E422BBEF5BC47C84C0074" reported-display-style="strikethrough"><enum>(A)</enum><text>by striking
<quote>For the purpose</quote> and inserting the following:</text>
<quoted-block changed="deleted" display-inline="no-display-inline" id="idDB302995135D4B31AC165D12CDA5AEF4" reported-display-style="strikethrough" style="OLC">
<paragraph changed="deleted" id="id26677E75BE16445C96E59184190622F4" reported-display-style="strikethrough"><enum>(1)</enum><header>In
general</header><text>For the purpose</text>
</paragraph><after-quoted-block>;
and</after-quoted-block></quoted-block>
</subparagraph><subparagraph changed="deleted" id="id2E1A58D9D3E644F49165332CDEEE3D03" reported-display-style="strikethrough"><enum>(B)</enum><text>by adding at the
end the following:</text>
<quoted-block changed="deleted" display-inline="no-display-inline" id="id5E9F2B232ACB4C8997EEA21A8CBB37EF" reported-display-style="strikethrough" style="OLC">
<paragraph changed="deleted" id="id3AC4C264E6A347E5941696DE10DE484D" reported-display-style="strikethrough"><enum>(2)</enum><header>Drug endangered
children rapid response teams</header><text>There are authorized to be
appropriated $2,500,000 for each of the fiscal years 2006 and 2007 to carry out
the provisions of subsection
(b)(9).</text>
</paragraph><after-quoted-block>.</after-quoted-block></quoted-block>
</subparagraph></paragraph></section><section changed="deleted" id="id84D3FFE68C574400A0892C174EC14F7D" reported-display-style="strikethrough"><enum>202.</enum><header>Local grants
for treatment of methamphetamine abuse and related conditions</header><text display-inline="no-display-inline">Subpart 1 of part B of title V of the
<act-name parsable-cite="PHSA">Public Health Service Act</act-name>
(<external-xref legal-doc="usc" parsable-cite="usc/42/290bb">42 U.S.C.
290bb</external-xref> et seq.) is amended—</text>
<paragraph changed="deleted" id="id739FCEBBE1014256837CA9B69E7DE5B5" reported-display-style="strikethrough"><enum>(1)</enum><text>by redesignating
the section 514 that relates to methamphetamine and appears after section 514A
as section 514B;</text>
</paragraph><paragraph changed="deleted" id="idC980D759B6CF4559A66026EE0437813A" reported-display-style="strikethrough"><enum>(2)</enum><text>in section 514B,
as redesignated—</text>
<subparagraph changed="deleted" id="idB1A8B110BDB54F8899619B837713CFB3" reported-display-style="strikethrough"><enum>(A)</enum><text>by amending
subsection (a)(1) to read as follows:</text>
<quoted-block changed="deleted" display-inline="no-display-inline" id="idC71F62812AA34DB3B313944AE87133E5" reported-display-style="strikethrough" style="OLC">
<paragraph changed="deleted" id="id276B0F753F704608A002B4692D171477" reported-display-style="strikethrough"><enum>(1)</enum><header>Grants
authorized</header><text>The Secretary may award grants to States, political
subdivisions of States, American Indian Tribes, and private, nonprofit entities
to provide treatment for methamphetamine
abuse.</text>
</paragraph><after-quoted-block>;</after-quoted-block></quoted-block>
</subparagraph><subparagraph changed="deleted" id="id3BDD187368714B2B9157D14A6D307A44" reported-display-style="strikethrough"><enum>(B)</enum><text>by amending
subsection (b) to read as follows:</text>
<quoted-block changed="deleted" display-inline="no-display-inline" id="id8A692A23215244A68B0BCCF11AB02C5A" reported-display-style="strikethrough" style="OLC">
<subsection changed="deleted" id="idD644759C9B3043B08786B597266879BC" reported-display-style="strikethrough"><enum>(b)</enum><header>Priority for
rural areas</header><text>In awarding grants under subsection (a), the
Secretary shall give priority to entities that will serve rural areas
experiencing an increase in methamphetamine
abuse.</text>
</subsection><after-quoted-block>;
and</after-quoted-block></quoted-block>
</subparagraph><subparagraph changed="deleted" id="id170986E1A4E74B399D1381D12F6F4E18" reported-display-style="strikethrough"><enum>(C)</enum><text>in subsection
(d)(1), by striking <quote>2000</quote> and all that follows and inserting
<quote>2005 and such sums as may be necessary for each of fiscal years 2006
through 2009</quote>; and</text>
</subparagraph></paragraph><paragraph changed="deleted" id="id167960168CBB4179ABD24153243C92E4" reported-display-style="strikethrough"><enum>(3)</enum><text>by inserting after
section 514B, as redesignated, the following:</text>
<quoted-block act-name="" changed="deleted" display-inline="no-display-inline" id="id281C0526F0B44321BB9CCF6D67189266" reported-display-style="strikethrough" style="OLC">
<section changed="deleted" id="idA27DFE715A8A42C5BDFDED9B08122220" reported-display-style="strikethrough"><enum>514C.</enum><header>Methamphetamine
research, training, and technical assistance center</header>
<subsection changed="deleted" id="id1347AA19A97C47DC8B3CA601ACC80CE9" reported-display-style="strikethrough"><enum>(a)</enum><header>Program
authorized</header><text>The Secretary, acting through the Administrator, and
in consultation with the Director of the National Institutes of Health, shall
award grants to, or enter into contracts with, public or private, nonprofit
entities to establish a research, training, and technical assistance center to
carry out the activities described in subsection (d).</text>
</subsection><subsection changed="deleted" id="idC9D62E0B0EC647DFA04D8DE4FC02742F" reported-display-style="strikethrough"><enum>(b)</enum><header>Application</header><text>A
public or private, nonprofit entity seeking a grant or contract under
subsection (a) shall submit an application to the Secretary at such time, in
such manner, and containing such information as the Secretary may
require.</text>
</subsection><subsection changed="deleted" id="idB10724368B514994A8585108D891A699" reported-display-style="strikethrough"><enum>(c)</enum><header>Condition</header><text>In
awarding grants or entering into contracts under subsection (a), the Secretary
shall ensure that not less than 1 of the centers will focus on methamphetamine
abuse in rural areas.</text>
</subsection><subsection changed="deleted" id="idC91FA054EA4E463981054455D4E8C931" reported-display-style="strikethrough"><enum>(d)</enum><header>Authorized
activities</header><text>Each center established under this section
shall—</text>
<paragraph changed="deleted" id="id4CB82709C475464297868BBE5C83281D" reported-display-style="strikethrough"><enum>(1)</enum><text>engage in research
and evaluation of the effectiveness of treatment modalities for the treatment
of methamphetamine abuse;</text>
</paragraph><paragraph changed="deleted" id="id447317F25FE14FB89B769EAFFB6563A6" reported-display-style="strikethrough"><enum>(2)</enum><text>disseminate
information to public and private entities on effective treatments for
methamphetamine abuse;</text>
</paragraph><paragraph changed="deleted" id="id6024EC2C420A4C7F9148BE3C316F102B" reported-display-style="strikethrough"><enum>(3)</enum><text>provide direct
technical assistance to States, political subdivisions of States, and private
entities on how to improve the treatment of methamphetamine abuse; and</text>
</paragraph><paragraph changed="deleted" id="idE58D90CB829C46A586A3355B68997823" reported-display-style="strikethrough"><enum>(4)</enum><text>provide training
on the effects of methamphetamine use and on effective ways of treating
methamphetamine abuse to substance abuse treatment professionals and community
leaders.</text>
</paragraph></subsection><subsection changed="deleted" id="idAF858F06597A45BB936173AA6AFE297B" reported-display-style="strikethrough"><enum>(e)</enum><header>Reports</header><text>Each
grantee or contractor under this section shall annually submit a report to the
Administrator that contains—</text>
<paragraph changed="deleted" id="id17B3FEA441D446F795472EDFA4BD1486" reported-display-style="strikethrough"><enum>(1)</enum><text>a description of
the previous year's activities of the center established under this
section;</text>
</paragraph><paragraph changed="deleted" id="id968244D388944AE6A250DEFB95B5505B" reported-display-style="strikethrough"><enum>(2)</enum><text>effective
treatment modalities undertaken by the center; and</text>
</paragraph><paragraph changed="deleted" id="id2507CBC3D0914A5BB7295F51A01FC86E" reported-display-style="strikethrough"><enum>(3)</enum><text>evidence to
demonstrate that such treatment modalities were successful.</text>
</paragraph></subsection><subsection changed="deleted" id="idD5A67ABC8DC54C2B823B8099912E3103" reported-display-style="strikethrough"><enum>(f)</enum><header>Authorization of
appropriations</header><text>There are authorized to be appropriated to carry
out this section $3,000,000 for fiscal year 2006 and such sums as may be
necessary for each of fiscal years 2007 and
2008.</text>
</subsection></section><after-quoted-block>.</after-quoted-block></quoted-block>
</paragraph></section><section changed="deleted" id="id30CEA7B719664C83890C9F0402D4E38A" reported-display-style="strikethrough"><enum>203.</enum><header>Methamphetamine
precursor monitoring grants</header>
<subsection changed="deleted" id="idA5AA316498254970A37C2C59E31F4BD2" reported-display-style="strikethrough"><enum>(a)</enum><header>Grants
authorized</header><text>The Attorney General, acting through the Bureau of
Justice Assistance, may award grants to States to establish methamphetamine
precursor monitoring programs.</text>
</subsection><subsection changed="deleted" id="idB4607AEC225E40819FA69C94B6117641" reported-display-style="strikethrough"><enum>(b)</enum><header>Purpose</header><text>The
purpose of the grant program established under this section is to—</text>
<paragraph changed="deleted" id="id8CD5F88167104B51A03DF729BE21DAB4" reported-display-style="strikethrough"><enum>(1)</enum><text>prevent the sale
of methamphetamine precursors, such as pseudoephedrine, to individuals in
quantities so large that the only reasonable purpose of the purchase would be
to manufacture methamphetamine;</text>
</paragraph><paragraph changed="deleted" id="id580C32AB815E4304953A4D7BC663083A" reported-display-style="strikethrough"><enum>(2)</enum><text>educate businesses
that legally sell methamphetamine precursors of the need to balance the
legitimate need for lawful access to medication with the risk that those
substances may be used to manufacture methamphetamine; and</text>
</paragraph><paragraph changed="deleted" id="idD62BA5F1510441D9B64CEFEB5FC55FC9" reported-display-style="strikethrough"><enum>(3)</enum><text>recalibrate
existing prescription drug monitoring programs designed to track the sale of
controlled substances to also track the sale of pseudoephedrine in any amount
greater than 6 grams.</text>
</paragraph></subsection><subsection changed="deleted" id="id38499ABC2DB244EA8A85D20E9F473B65" reported-display-style="strikethrough"><enum>(c)</enum><header>Use of grant
funds</header><text>Grant funds awarded to States under this section may be
used to—</text>
<paragraph changed="deleted" id="id02AABDFF30564A0CA699D888FD5FDD51" reported-display-style="strikethrough"><enum>(1)</enum><text>implement a
methamphetamine precursor monitoring program, including hiring personnel and
purchasing computer hardware and software designed to monitor methamphetamine
precursor purchases;</text>
</paragraph><paragraph changed="deleted" id="id7316020E7A68411988B55AAF9DB59B17" reported-display-style="strikethrough"><enum>(2)</enum><text>expand existing
methamphetamine precursor or prescription drug monitoring programs to
accomplish the purposes described in subsection (b);</text>
</paragraph><paragraph changed="deleted" id="id9F42D35EC85C40FF8A0524D7D93BFE77" reported-display-style="strikethrough"><enum>(3)</enum><text>pay for training
and technical assistance for law enforcement personnel and employees of
businesses that lawfully sell substances, which may be used as methamphetamine
precursors;</text>
</paragraph><paragraph changed="deleted" id="id4EE5D446C4C04EDB9602B41B9CFA4C55" reported-display-style="strikethrough"><enum>(4)</enum><text>improve
information sharing between adjacent States through enhanced connectivity;
or</text>
</paragraph><paragraph changed="deleted" id="idBEE6427DF7C04EE5927F6727FFCF44F9" reported-display-style="strikethrough"><enum>(5)</enum><text>make grants to
subdivisions of the State to implement methamphetamine precursor monitoring
programs.</text>
</paragraph></subsection><subsection changed="deleted" id="idF1362E5EDA0142649317E6A5C67144A4" reported-display-style="strikethrough"><enum>(d)</enum><header>Application</header><text>Any
State seeking a grant under this section shall submit an application to the
Attorney General at such time, in such manner, and containing such information
as the Attorney General may require.</text>
</subsection><subsection changed="deleted" id="id35B2CB447C25482887600FA0ECCBD94F" reported-display-style="strikethrough"><enum>(e)</enum><header>Authorization of
appropriations</header><text>There are authorized to be appropriated $5,000,000
for each of the fiscal years 2006 and 2007 to carry out the provisions of this
section.</text>
</subsection></section>
1.This Act may be cited as the
Combat Meth Act of
2005
.
<enum>I</enum><header>Enforcement</header>
<subtitle changed="added" id="idDCE4F3F5B8724306AE3917FE23ECE0C9" reported-display-style="italic"><enum>A</enum><header>Amendments to Controlled
Substances Act</header>
<section changed="added" commented="no" id="id6e39b95e-6b94-4847-b5a7-86a125f85452" reported-display-style="italic"><enum>101.</enum><header>Pseudoephedrine and
ephedrine amendments to Controlled Substances Act</header>
<subsection changed="added" commented="no" id="id1299b6f7-463c-4c5c-b37a-138aee04b4a6" reported-display-style="italic"><enum>(a)</enum><header>Addition of
pseudoephedrine and ephedrine to schedule V</header><text>The matter under
schedule V in section 202(c) of the Controlled Substances Act (21 U.S.C.
812(c)) is amended by adding at the end the following:</text>
<quoted-block changed="added" display-inline="no-display-inline" id="id72CF9376517E43E5956413129F7F6A02" reported-display-style="italic" style="OLC">
<paragraph changed="added" commented="no" display-inline="no-display-inline" id="id601ca24e-7792-4e11-97e3-9376e8b1af3b" reported-display-style="italic"><enum>(6)</enum><text>Any detectable quantity
of pseudoephedrine or ephedrine, their salts or optical isomers, or salts of
optical
isomers.</text>
</paragraph><after-quoted-block>.</after-quoted-block></quoted-block>
</subsection><subsection changed="added" id="id79D458D73F534B6789A3D0E6E3358131" reported-display-style="italic"><enum>(b)</enum><header>Prescriptions</header><text>Section
309(c) of the Controlled Substances Act (21 U.S.C. 829(c)) is amended—</text>
<paragraph changed="added" id="IDcf31ec23553b403a91e1df2e37fe2691" reported-display-style="italic"><enum>(1)</enum><text>by striking <quote>No
controlled substance</quote> and inserting the following:</text>
<quoted-block changed="added" display-inline="no-display-inline" id="id8E5ACBB7487949C188F398150B160E2E" reported-display-style="italic" style="OLC">
<paragraph changed="added" id="idF5A859F225CF4833BF3BBCAB9C0443FC" reported-display-style="italic"><enum>(1)</enum><header>In
general</header><text>No controlled
substance</text>
</paragraph><after-quoted-block>;
and</after-quoted-block></quoted-block>
</paragraph><paragraph changed="added" id="ID61ff5c25c11b4f71beec17b115b38457" reported-display-style="italic"><enum>(2)</enum><text>by adding at the end the
following:</text>
<quoted-block changed="added" display-inline="no-display-inline" id="idE736DB9233BE4B7EBCE941F8EC4FA9D0" reported-display-style="italic" style="OLC">
<paragraph changed="added" id="ID44c979ba401b4f2b92fe0739041696e3" reported-display-style="italic"><enum>(2)</enum><header>Retail distributors and
pharmacies</header><text>If a controlled substance described in paragraph (6)
of schedule V is dispensed or sold at retail by a retail distributor or a
pharmacy, the retail distributor or pharmacy shall ensure the following:</text>
<subparagraph changed="added" id="ID7ba82ffa8e794bd981b5cf03307b5f99" reported-display-style="italic"><enum>(A)</enum><header>Qualifications of
dispenser</header><text>The substance shall be dispensed or sold at retail only
by practitioner, pharmacist, or an individual under the supervision of a
pharmacist as permitted by the State.</text>
</subparagraph><subparagraph changed="added" id="IDce75fbcb6c6240c7bb899c60ced93ed0" reported-display-style="italic"><enum>(B)</enum><header>Requirements for
purchaser</header><text>Any person purchasing, receiving, or otherwise
acquiring any such substance shall, prior to taking possession—</text>
<clause changed="added" id="IDe411bc206a2246cba9ec6bfa4973bd29" reported-display-style="italic"><enum>(i)</enum><text>provide an approved
Federal or State-issued photo identification or an alternative form of
identification authorized by the Attorney General; and</text>
</clause><clause changed="added" id="ID134a91e5f3cb4dfc9a6ba7b69ac9161d" reported-display-style="italic"><enum>(ii)</enum><text>sign or make an entry in
a written or electronic log that conforms with the regulations under paragraph
(4) documenting—</text>
<subclause changed="added" id="IDc47e451cb9674f119182c53f482b7576" reported-display-style="italic"><enum>(I)</enum><text>the date of the
transaction;</text>
</subclause><subclause changed="added" id="ID051555fa546849b083d192d1e5b6b3d2" reported-display-style="italic"><enum>(II)</enum><text>the name of the person;
and</text>
</subclause><subclause changed="added" id="IDfe5a263784344f49ba1a4bd7ba0562a7" reported-display-style="italic"><enum>(III)</enum><text>the name and the amount
of the controlled substance described in paragraph (6) of schedule V purchased,
received, or otherwise acquired.</text>
</subclause></clause></subparagraph><subparagraph changed="added" id="ID57cc42b74f9d4aaeaa6e861169c71eb0" reported-display-style="italic"><enum>(C)</enum><header>Limitation on amount of
purchase</header><text>No person shall purchase, receive, or otherwise acquire
more than 7.5 grams of a controlled substance described in paragraph (6) of
schedule V within any 30-day period.</text>
</subparagraph></paragraph><paragraph changed="added" id="id6F3E0DB5CB8E47DAAF629D854CFD1DE4" reported-display-style="italic"><enum>(3)</enum><header>Exemptions</header>
<subparagraph changed="added" id="ID0a832419a6b84192b798db560c1a61cc" reported-display-style="italic"><enum>(A)</enum><header>In
general</header><text>The Attorney General, by rule, may exempt a product from
paragraph (6) of schedule V if the Attorney General determines that the product
cannot be used in the illegal manufacture of methamphetamine or any other
controlled dangerous substance.</text>
</subparagraph><subparagraph changed="added" id="ID1e1babd8679d4436832eec6241341293" reported-display-style="italic"><enum>(B)</enum><header>Different
formulation</header>
<clause changed="added" id="id23719078E41B4B679DBC2F751628A56B" reported-display-style="italic"><enum>(i)</enum><header>In
general</header><text>The Attorney General, upon the application of a
manufacturer of a drug product, may exempt a product from paragraph (6) of
schedule V if the Attorney General determines that the product has been
formulated in such a way as to effectively prevent the conversion of the active
ingredient into methamphetamine.</text>
</clause><clause changed="added" id="idE8D72C22AC714E789B901A071C19FB1D" reported-display-style="italic"><enum>(ii)</enum><header>Sense of
Congress</header><text>It is the sense of Congress that the Secretary of Health
and Human Services should consider a product under clause (i) to be subject to
the performance goals established by the Commissioner of Food and Drugs for
priority drugs.</text>
</clause></subparagraph><subparagraph changed="added" id="ID5e739ef031b94c67bd07306a54a17548" reported-display-style="italic"><enum>(C)</enum><header>Special
exceptions</header><text>The Attorney General, by rule, may authorize the sale
of a controlled substance described in paragraph (6) of schedule V by persons
other than a practitioner, and at a location other than a pharmacy if—</text>
<clause changed="added" id="ID304809d77cce4be6b08bf98618340da1" reported-display-style="italic"><enum>(i)</enum><text>the Attorney
General—</text>
<subclause changed="added" id="ID441fe3184c21469a84cc7928548f2330" reported-display-style="italic"><enum>(I)</enum><text>determines that the
retail facility is located within a commercial service airport, and sells the
substance packaged in liquid and liquid filled gelcaps only, each single sales
package containing not more than 360 mg, per person, in a 24 hour period;
or</text>
</subclause><subclause changed="added" id="idA05B154EF6174DB6ACA469F76C8E99A3" reported-display-style="italic"><enum>(II)</enum><text>has issued an alternate
place of sale license to the retail location and has issued an alternate
dispenser license to the person authorized to make the sale under subsections
(i) and (j) of section 303, respectively;</text>
</subclause></clause><clause changed="added" id="ID1ecdcb98c1be4217a7c4dae3c2924f5b" reported-display-style="italic"><enum>(ii)</enum><text>the person dispensing
the controlled substance described in paragraph (6) of schedule V follows the
procedures set forth in this Act; and</text>
</clause><clause changed="added" id="idBA8568C1C9144636A6A352F62B520EAD" reported-display-style="italic"><enum>(iii)</enum><text>the person authorized
under section 303(i) dispensing the controlled substance described in paragraph
(6) of schedule V provides notification, in writing, of the intention to
dispense such substance pursuant to a special exception under this subparagraph
to each State and local law enforcement authority with jurisdiction to
investigate crimes involving controlled substances at such location.</text>
</clause></subparagraph><subparagraph changed="added" id="id183BF140D181451D986E4AE7E3AC183C" reported-display-style="italic"><enum>(D)</enum><header>Prescriptions</header><text>The
limit described in paragraph (2)(C) shall not apply to any quantity of such
substance dispensed under a valid prescription.</text>
</subparagraph></paragraph><paragraph changed="added" id="id378BEBF8CCE24B1B971F14BC90E90D25" reported-display-style="italic"><enum>(4)</enum><header>Regulations</header>
<subparagraph changed="added" id="idA1DD70C2EE0245A6B2C79E745AA5AEE0" reported-display-style="italic"><enum>(A)</enum><header>Rules for logs</header>
<clause changed="added" id="id6B2FA080F3484DB7AE720A1BB35AB973" reported-display-style="italic"><enum>(i)</enum><header>In
general</header><text>The Attorney General shall promulgate rules and
regulations—</text>
<subclause changed="added" id="idA9018CC2E94743728BF25DDBF7154EE2" reported-display-style="italic"><enum>(I)</enum><text>prescribing the content
and format of the log required in paragraph (2)(B)(ii);</text>
</subclause><subclause changed="added" id="idD146BE61524E4853B77A5FB140E2CD88" reported-display-style="italic"><enum>(II)</enum><text>establishing the manner
in which the information in the log required in paragraph (2)(B)(ii) shall be
reported to law enforcement authorities; and</text>
</subclause><subclause changed="added" id="ID03d8e1b66e1f4659bca77feb1bad405f" reported-display-style="italic"><enum>(III)</enum><text>prohibiting accessing,
using, or sharing the information in the log for any purpose other than to
ensure compliance with this Act or to facilitate a product recall necessary to
protect public health and safety.</text>
</subclause></clause><clause changed="added" id="idB7AB3243513F45F68B05B5518123BBA1" reported-display-style="italic"><enum>(ii)</enum><header>Misrepresentation
warning</header><text>The rules and regulations under clause (i) shall require
that the log explain the potential consequences of false statements or
misrepresentations, including requiring that the following statement is
prominently presented: <quote>NOTE: PENALTY FOR MISREPRESENTATION – Any
misrepresentation (by omission or concealment, or by misleading, false, or
partial answers may result in prosecution pursuant to section 1001 of title 18,
United States Code, which makes it a criminal offense, punishable by a maximum
of 5 years imprisonment, $10,000 fine, or both, knowingly and willfully to make
a false statement or representation to any Department or Agency of the United
States as to any matter within the jurisdiction of any Department or Agency of
the United States.</quote></text>
</clause></subparagraph><subparagraph changed="added" id="id9C83810D2A094737ACA579AF904C329F" reported-display-style="italic"><enum>(B)</enum><header>Alternate
identification</header><text>The Attorney General shall promulgate rules and
regulations authorizing the acceptance of an alternate form of identification
under paragraph (2)(B)(i) to be used electronically.</text>
</subparagraph></paragraph><paragraph changed="added" id="id93E0EEEC266446F6847A3F9011828E00" reported-display-style="italic"><enum>(5)</enum><header>Good faith
protection</header><text>A retailer who in good faith releases information
maintained under this subsection for purposes of compliance with this Act to a
law enforcement or regulatory authority established pursuant to Federal or
State law is immune from civil liability unless the release constitutes gross
negligence or intentional, wanton, or willful
misconduct.</text>
</paragraph><after-quoted-block>.</after-quoted-block></quoted-block>
</paragraph></subsection><subsection changed="added" id="idD37C3CCA8ECB4A7D95DC143963026049" reported-display-style="italic"><enum>(c)</enum><header>Alternate place of
sales and dispensers</header><text>Section 303 of the Controlled Substances Act
(21 U.S.C. 823) is amended by adding at the end the following:</text>
<quoted-block changed="added" display-inline="no-display-inline" id="id15B71FCF9E6F4E6C94C6E57A6A6C74FA" reported-display-style="italic" style="OLC">
<subsection changed="added" id="idB124D89AA1604E3BB657AAAFC1F3E5A5" reported-display-style="italic"><enum>(i)</enum><header>Alternate place of
sales licenses</header>
<paragraph changed="added" id="id0E4EF869D9E7404DAD32659D98587830" reported-display-style="italic"><enum>(1)</enum><header>In
general</header><text>The Attorney General shall register an applicant to
dispense a controlled substance described in paragraph (6) of schedule V at a
location other than a pharmacy if the Attorney General determines that such
registration is consistent with the public interest.</text>
</paragraph><paragraph changed="added" id="id34057EBE223F4E8D8594C6E408414996" reported-display-style="italic"><enum>(2)</enum><header>Considerations</header><text>In
determining the public interest, the Attorney General shall consider—</text>
<subparagraph changed="added" id="ID917a195826a44c78902d3313be309888" reported-display-style="italic"><enum>(A)</enum><text>the applicant's
maintenance of effective controls against diversion of the controlled substance
described in paragraph (6) of schedule V into other than legitimate channels
equivalent to that of a pharmacy;</text>
</subparagraph><subparagraph changed="added" id="IDd6431a2b9cf24a9a9f4fc93c9f9e97fb" reported-display-style="italic"><enum>(B)</enum><text>the applicant's
compliance with applicable State and local law, including holding a valid
license issued by an appropriate State authority evidencing compliance with
subparagraph (A);</text>
</subparagraph><subparagraph changed="added" id="ID99e2ed7d80f44ee5969ef8702b8f9398" reported-display-style="italic"><enum>(C)</enum><text>the applicant's prior
conviction record under Federal and State laws; and</text>
</subparagraph><subparagraph changed="added" id="IDe214a1b31a6e41429313df7ddee17317" reported-display-style="italic"><enum>(D)</enum><text>such other factors as may
be relevant to and consistent with the public health and safety, including
accessibility to rural consumers.</text>
</subparagraph></paragraph><paragraph changed="added" id="ID05867f0c00b64856af2f51c295d02dfa" reported-display-style="italic"><enum>(3)</enum><header>State
licenses</header><text>If an applicant under paragraph (1) does not have a
valid State license as described in paragraph (2)(B), the Attorney General
shall not register the applicant for a license under this subsection.</text>
</paragraph></subsection><subsection changed="added" id="id74F3D219AFA242B4BC29B70A61F93E26" reported-display-style="italic"><enum>(j)</enum><header>Alternate Dispenser
Licenses</header>
<paragraph changed="added" id="ID538d3321b1d54a4f8ae626291e2de734" reported-display-style="italic"><enum>(1)</enum><header>In
general</header><text>The Attorney General shall register an applicant, other
than a practitioner, to dispense a controlled substance described in paragraph
(6) of schedule V at a location other than a pharmacy if the Attorney General
determines that such registration is consistent with the public
interest.</text>
</paragraph><paragraph changed="added" id="id965571507569418F839A38307B642B11" reported-display-style="italic"><enum>(2)</enum><header>Considerations</header><text>In
determining the public interest, the Attorney General shall consider—</text>
<subparagraph changed="added" id="IDd5c6049e8e274674ba6257a343e95bd8" reported-display-style="italic"><enum>(A)</enum><text>the applicant's
compliance with applicable State and local law, including holding a license
issued by an appropriate State authority evidencing a degree of suitability to
dispense the controlled substance described in paragraph (6) of schedule V
equivalent to that of a practitioner;</text>
</subparagraph><subparagraph changed="added" id="ID874504d725cb472f8c9ca34025c7441c" reported-display-style="italic"><enum>(B)</enum><text>the applicant's prior
conviction record under Federal and State laws; and</text>
</subparagraph><subparagraph changed="added" id="ID73ec6fe68ca643a19dd8c0e89812c99b" reported-display-style="italic"><enum>(C)</enum><text>such other factors as may
be relevant to and consistent with the public health and safety, including
accessibility to rural consumers.</text>
</subparagraph></paragraph><paragraph changed="added" id="IDb72226c7a8be448e9d0193c6d7c625aa" reported-display-style="italic"><enum>(3)</enum><header>State
licenses</header><text>If an applicant under paragraph (1) does not have a
valid State license as described in paragraph (2)(B), the Attorney General
shall not register the applicant for a license under this
subsection.</text>
</paragraph></subsection><after-quoted-block>.</after-quoted-block></quoted-block>
</subsection><subsection changed="added" commented="no" display-inline="no-display-inline" id="IDb7c6ffb7fdd8410682a720caf53ef485" reported-display-style="italic"><enum>(d)</enum><header>Theft
prevention</header><text>Notwithstanding paragraph (6) of schedule V of section
202 of the Controlled Substances Act (21 U.S.C. 812), as added by subsection
(a), persons registered with the Drug Enforcement Administration to manufacture
or distribute controlled substances shall maintain adequate security and
provide effective controls and procedures to guard against theft and diversion,
but shall not otherwise be required to meet the meet the storage, reporting,
recordkeeping, or physical security control requirements (such as a cage or
vault) for controlled substances in schedule V containing pseudoephedrine or
ephedrine.</text>
</subsection><subsection changed="added" id="ID500b6bcd70b24f3ab022f45966454d3b" reported-display-style="italic"><enum>(e)</enum><header>State penalties and
pediatric products</header><text>Nothing in this Act shall be construed
to—</text>
<paragraph changed="added" id="id67C51BD0238F418C9A5BB34E74766BA2" reported-display-style="italic"><enum>(1)</enum><text>prevent a State or
political subdivision of a State from adopting and enforcing penalties that are
different from, in addition to, or otherwise not identical with, the penalties
that apply under the Controlled Substances Act (28 U.S.C. 801 et seq.);
or</text>
</paragraph><paragraph changed="added" id="id560804E76F0F41BB81B505DF1E0323C8" reported-display-style="italic"><enum>(2)</enum><text>prevent a State or
political subdivision of a State from permitting the sale of pediatric products
containing pseudoephedrine or ephedrine, their salts or optical insomers, or
salts of optical isomers where the pediatric product—</text>
<subparagraph changed="added" commented="no" display-inline="no-display-inline" id="id70969DEEA4D04EB4A329D11E0776844A" reported-display-style="italic"><enum>(A)</enum><text>is primarily intended for
administration, according to label instructions, to children under 12 years of
age and either—</text>
<clause changed="added" id="ID6a85c3ed19b547a4bb8c26a44f1ca372" reported-display-style="italic"><enum>(i)</enum><text>in solid dosage form,
individual dosage units do not exceed 15 milligrams of ephedrine or
pseudoephedrine; or</text>
</clause><clause changed="added" id="IDc79ebc43b3054034a6be4ea57a961749" reported-display-style="italic"><enum>(ii)</enum><text>in liquid form,
recommended dosage units, according to label instructions, do not exceed 15
milligrams of ephedrine or pseudoephedrine per 5 milliliters of liquid product;
or</text>
</clause></subparagraph><subparagraph changed="added" id="IDd7fe57b4748340b791977e7294deb929" reported-display-style="italic"><enum>(B)</enum><text>is in liquid form—</text>
<clause changed="added" id="idA0D08976F6284B639B352AB6EB38D6E0" reported-display-style="italic"><enum>(i)</enum><text>primarily intended for
administration to children under 2 years of age;</text>
</clause><clause changed="added" id="idE4989B48ACB14B1A8B2082364A3CC751" reported-display-style="italic"><enum>(ii)</enum><text>the recommended dosage
of which does not exceed 2 milliliters; and</text>
</clause><clause changed="added" id="id690C4C76E54C4F57A382668C33F72090" reported-display-style="italic"><enum>(iii)</enum><text>the total package
content is not more than 1 fluid ounce.</text>
</clause></subparagraph></paragraph></subsection><subsection changed="added" commented="no" committee-id="SSJU00" display-inline="no-display-inline" id="idD400C97DB9174A66819CA2E3231293E8" reported-display-style="italic"><enum>(f)</enum><header>Effective
dates</header>
<paragraph changed="added" commented="no" committee-id="SSJU00" display-inline="no-display-inline" id="idF5B7365F0E0F4F779B4C2D06B2052413" reported-display-style="italic"><enum>(1)</enum><header>Only active
ingredient</header><text>This section and the amendments made by this section
shall take effect with regard to any substance in which ephedrine or
pseudoephedrine is the only active ingredient 90 days after the date of
enactment of this Act.</text>
</paragraph><paragraph changed="added" commented="no" committee-id="SSJU00" display-inline="no-display-inline" id="id2556E7C25E254B59889B5B9D29458001" reported-display-style="italic"><enum>(2)</enum><header>Other
products</header><text>This section and the amendments made by this section
shall take effect with regard to any substance other than a substance described
in paragraph (1) on January 1, 2007.</text>
</paragraph></subsection></section><section changed="added" commented="no" display-inline="no-display-inline" id="id14DBA4C9DAA841EF9A5B1F041DF2F33B" reported-display-style="italic"><enum>102.</enum><header>Employer screening of
employees working with controlled substances</header><text display-inline="no-display-inline">Part C of the Controlled Substances Act (21
U.S.C. 821 et seq.) is amended by adding at the end the following:</text>
<quoted-block changed="added" display-inline="no-display-inline" id="id45E81D18E6DF4DE2BC0916B77CF37D07" reported-display-style="italic" style="traditional"><section changed="added" commented="no" display-inline="no-display-inline" id="id0FAA7187F6C34D8588171D7EAF4636C2" reported-display-style="italic" section-type="subsequent-section"><enum>311.</enum><header>Applicants and
employees</header><text display-inline="yes-display-inline">Persons registered with the Drug
Enforcement Administration to manufacture, deliver, distribute, or dispense
controlled substances shall take reasonable steps to guard against hiring
persons who may, as a result of their employment, have access to and become
involved in the theft and diversion of controlled substances, including,
notwithstanding State law, asking applicants for employment whether they have
been convicted of any crime involving or related to controlled
substances.</text>
</section><after-quoted-block>.</after-quoted-block></quoted-block>
</section></subtitle><enum>II</enum><header>Education, prevention,
and treatment</header>
<section changed="added" id="id80ef9394-f643-4a89-9351-00a0e8a605fa" reported-display-style="italic"><enum>201.</enum><header>Grants for services
for children of substance abusers</header><text display-inline="no-display-inline">Section 519 of the Public Health Service Act
(42 U.S.C. 290bb–25) is amended—</text>
<paragraph changed="added" id="ide399a297-4762-4530-8d47-d380aac36e7d" reported-display-style="italic"><enum>(1)</enum><text display-inline="yes-display-inline">in subsection (b), by inserting after
paragraph (8) the following:</text>
<quoted-block changed="added" display-inline="no-display-inline" id="idb0838d9d-0cb9-4b68-a00f-490f7a81adae" reported-display-style="italic" style="OLC">
<paragraph changed="added" id="id41d1abe6-3b01-4cec-8854-2593d205b1f0" reported-display-style="italic"><enum>(9)</enum><text>Development of drug
endangered children rapid response teams that will intervene on behalf of
children exposed to methamphetamine as a result of residing or being present in
a home-based clandestine drug
laboratory.</text>
</paragraph><after-quoted-block>;
and</after-quoted-block></quoted-block>
</paragraph><paragraph changed="added" id="id99518f46-e9bf-403d-8ff4-25ca44c8c875" reported-display-style="italic"><enum>(2)</enum><text>in subsection (o)—</text>
<subparagraph changed="added" id="idde96f396-0815-4d73-8b0d-0d6193c73e04" reported-display-style="italic"><enum>(A)</enum><text>by striking <quote>For
the purpose</quote> and inserting the following:</text>
<quoted-block changed="added" display-inline="no-display-inline" id="id0552923b-937c-48fd-809d-55087cad0e41" reported-display-style="italic" style="OLC">
<paragraph changed="added" id="idb0d1594a-29fe-432e-ac34-9f89056d874c" reported-display-style="italic"><enum>(1)</enum><header>In
general</header><text>For the purpose</text>
</paragraph><after-quoted-block>;
and</after-quoted-block></quoted-block>
</subparagraph><subparagraph changed="added" id="id38ac30b7-4e73-442d-b7ef-793bef2ee941" reported-display-style="italic"><enum>(B)</enum><text>by adding at the end the
following:</text>
<quoted-block changed="added" display-inline="no-display-inline" id="id7c941b32-3a20-4bb8-b8f7-7aeac002138a" reported-display-style="italic" style="OLC">
<paragraph changed="added" id="id4f88a1a8-2452-4119-afeb-2d5306810453" reported-display-style="italic"><enum>(2)</enum><header>Drug endangered
children rapid response teams</header><text>There are authorized to be
appropriated $2,500,000 for each of the fiscal years 2006 and 2007 to carry out
the provisions of subsection
(b)(9).</text>
</paragraph><after-quoted-block>.</after-quoted-block></quoted-block>
</subparagraph></paragraph></section><section changed="added" id="idb83927ea-c1ed-422d-8623-ae683fa934d5" reported-display-style="italic"><enum>202.</enum><header>Local grants for
treatment of methamphetamine abuse and related conditions</header><text display-inline="no-display-inline">Subpart 1 of part B of title V of the
<act-name parsable-cite="PHSA">Public Health Service Act</act-name>
(<external-xref legal-doc="usc" parsable-cite="usc/42/290bb">42 U.S.C.
290bb</external-xref> et seq.) is amended—</text>
<paragraph changed="added" id="idb91eebaa-c5d2-459a-b213-bc315755c5c3" reported-display-style="italic"><enum>(1)</enum><text>by redesignating section
514 that relates to methamphetamine and appears after section 514A as section
514B;</text>
</paragraph><paragraph changed="added" id="id5bd735dd-ecd0-48db-b9f1-61c60959ecb7" reported-display-style="italic"><enum>(2)</enum><text>in section 514B, as
redesignated—</text>
<subparagraph changed="added" id="idc3e62e0a-0eb4-4806-955b-82aa3e4a95af" reported-display-style="italic"><enum>(A)</enum><text>by amending subsection
(a)(1) to read as follows:</text>
<quoted-block changed="added" display-inline="no-display-inline" id="idb2cc6a96-37d0-4e9c-bcd4-5e24d5756dd7" reported-display-style="italic" style="OLC">
<paragraph changed="added" id="id4a756eb7-2528-427e-814c-80e6b8ae5b40" reported-display-style="italic"><enum>(1)</enum><header>Grants
authorized</header><text>The Secretary may award grants to States, political
subdivisions of States, American Indian Tribes, and private, nonprofit entities
to provide treatment for methamphetamine
abuse.</text>
</paragraph><after-quoted-block>;</after-quoted-block></quoted-block>
</subparagraph><subparagraph changed="added" id="idd46a8af7-054d-4e8a-ab54-78b111f16404" reported-display-style="italic"><enum>(B)</enum><text>by amending subsection
(b) to read as follows:</text>
<quoted-block changed="added" display-inline="no-display-inline" id="idbbb0b678-723b-4cba-ba67-bc7eeafbb021" reported-display-style="italic" style="OLC">
<subsection changed="added" id="ida30cfea3-3517-47de-b54d-eba1fcb7d3a2" reported-display-style="italic"><enum>(b)</enum><header>Priority for high need
States</header><text>In awarding grants under subsection (a), the Secretary
shall give priority to entities that will serve rural or urban areas
experiencing an increase in methamphetamine abuse in States with addiction
rates in excess of the national rate.</text>
</subsection><after-quoted-block>;
and</after-quoted-block></quoted-block>
</subparagraph><subparagraph changed="added" id="id6a972d31-a17d-477b-b786-eddbfed8c828" reported-display-style="italic"><enum>(C)</enum><text>in subsection (d)(1), by
striking <quote>2000</quote> and all that follows and inserting <quote>2005 and
such sums as may be necessary for each of fiscal years 2006 through
2009</quote>; and</text>
</subparagraph></paragraph><paragraph changed="added" id="idfb2b4e81-d499-4b68-923f-a8fc67f1eaad" reported-display-style="italic"><enum>(3)</enum><text>by inserting after
section 514B, as redesignated, the following:</text>
<quoted-block act-name="" changed="added" display-inline="no-display-inline" id="idbe1279d8-f232-4ec6-b000-dd2937ebb373" reported-display-style="italic" style="OLC">
<section changed="added" id="idf5384516-0a33-4192-8468-6da57f64c8dc" reported-display-style="italic"><enum>514C.</enum><header>Methamphetamine
research, training, and technical assistance center</header>
<subsection changed="added" id="idc2dadee9-d17c-4650-8fc3-9cdb54719d3b" reported-display-style="italic"><enum>(a)</enum><header>Program
authorized</header><text>The Secretary, acting through the Administrator, and
in consultation with the Director of the National Institutes of Health, shall
award grants to, or enter into contracts with, public or private, nonprofit
entities to establish a research, training, and technical assistance center to
carry out the activities described in subsection (d).</text>
</subsection><subsection changed="added" id="id4bdb95c2-b89a-499a-ae8b-9ddff407dc01" reported-display-style="italic"><enum>(b)</enum><header>Application</header><text>A
public or private, nonprofit entity seeking a grant or contract under
subsection (a) shall submit an application to the Secretary at such time, in
such manner, and containing such information as the Secretary may
require.</text>
</subsection><subsection changed="added" id="idaae14175-4eac-4313-9413-83ace8b4ebd8" reported-display-style="italic"><enum>(c)</enum><header>Condition</header><text>In
awarding grants or entering into contracts under subsection (a), the Secretary
shall ensure that not less than 1 of the centers will focus on methamphetamine
abuse in rural areas.</text>
</subsection><subsection changed="added" id="id4c94937e-c7d4-48fb-b149-5ec4bf3b1c37" reported-display-style="italic"><enum>(d)</enum><header>Authorized
activities</header><text>Each center established under this section
shall—</text>
<paragraph changed="added" id="id9d3286fd-1c60-4364-8836-7b1d32924066" reported-display-style="italic"><enum>(1)</enum><text>engage in research and
evaluation of the effectiveness of treatment modalities for the treatment of
methamphetamine abuse;</text>
</paragraph><paragraph changed="added" id="idc99e134d-75c1-4853-b711-c38d9fe7eedd" reported-display-style="italic"><enum>(2)</enum><text>disseminate information
to public and private entities on effective treatments for methamphetamine
abuse;</text>
</paragraph><paragraph changed="added" id="id0f58ae74-6143-4c76-a467-f385a2545c1d" reported-display-style="italic"><enum>(3)</enum><text>provide direct technical
assistance to States, political subdivisions of States, and private entities on
how to improve the treatment of methamphetamine abuse; and</text>
</paragraph><paragraph changed="added" id="idd3c37b77-adfd-468b-817b-c7c4806c3c64" reported-display-style="italic"><enum>(4)</enum><text>provide training on the
effects of methamphetamine use and on effective ways of treating
methamphetamine abuse to substance abuse treatment professionals and community
leaders.</text>
</paragraph></subsection><subsection changed="added" id="id9f8c1c36-5c89-4cb2-aa3b-9295ec3d0f94" reported-display-style="italic"><enum>(e)</enum><header>Reports</header><text>Each
grantee or contractor under this section shall annually submit a report to the
Administrator that contains—</text>
<paragraph changed="added" id="idf2ef9e66-9790-4baf-94e8-1e7d396a10ab" reported-display-style="italic"><enum>(1)</enum><text>a description of the
previous year's activities of the center established under this section;</text>
</paragraph><paragraph changed="added" id="idb1c46390-46db-47fc-8436-6db3a4abcb50" reported-display-style="italic"><enum>(2)</enum><text>effective treatment
modalities undertaken by the center; and</text>
</paragraph><paragraph changed="added" id="id518ba431-a341-4083-9113-d6035c1c6993" reported-display-style="italic"><enum>(3)</enum><text>evidence to demonstrate
that such treatment modalities were successful.</text>
</paragraph></subsection><subsection changed="added" id="idddef325a-5106-424f-bc30-8bcc8dc56c80" reported-display-style="italic"><enum>(f)</enum><header>Authorization of
appropriations</header><text>There are authorized to be appropriated to carry
out this section $3,000,000 for fiscal year 2006 and such sums as may be
necessary for each of fiscal years 2007 and
2008.</text>
</subsection></section><after-quoted-block>.</after-quoted-block></quoted-block>
</paragraph></section><section changed="added" id="idbd99c6d1-2e19-461e-b311-d5c7a10593b2" reported-display-style="italic"><enum>203.</enum><header>Methamphetamine
precursor monitoring grants</header>
<subsection changed="added" id="idfb5aa0be-e082-4e83-9ce4-ce1387426485" reported-display-style="italic"><enum>(a)</enum><header>Grants
authorized</header><text>The Attorney General, acting through the Bureau of
Justice Assistance, may award grants to States to establish methamphetamine
precursor monitoring programs.</text>
</subsection><subsection changed="added" id="id250dfc28-34bf-44a0-9081-62bdc9e4d6cb" reported-display-style="italic"><enum>(b)</enum><header>Purpose</header><text>The
purpose of the grant program established under this section is to—</text>
<paragraph changed="added" id="id88490d28-72d8-499f-9ee8-5825160aab92" reported-display-style="italic"><enum>(1)</enum><text>prevent the sale of
methamphetamine precursors, such as pseudoephedrine and ephedrine, to
individuals in quantities so large that the only reasonable purpose of the
purchase would be to manufacture methamphetamine;</text>
</paragraph><paragraph changed="added" id="id1cbff553-0533-4ea1-a94d-c2fef5bc07bf" reported-display-style="italic"><enum>(2)</enum><text>educate businesses that
legally sell methamphetamine precursors of the need to balance the legitimate
need for lawful access to medication with the risk that those substances may be
used to manufacture methamphetamine; and</text>
</paragraph><paragraph changed="added" id="id826822c6-2475-42b6-99dc-83b38367a174" reported-display-style="italic"><enum>(3)</enum><text>recalibrate existing
prescription drug monitoring programs designed to track the sale of controlled
substances to also track the sale of pseudoephedrine or ephedrine in any amount
greater than 6 grams.</text>
</paragraph></subsection><subsection changed="added" id="idf56571bb-7389-44f5-9537-131695425901" reported-display-style="italic"><enum>(c)</enum><header>Use of grant
funds</header><text>Grant funds awarded to States under this section may be
used to—</text>
<paragraph changed="added" id="id0f03e04f-d2b6-4365-8259-f01ab1d5e68a" reported-display-style="italic"><enum>(1)</enum><text>implement a
methamphetamine precursor monitoring program, including hiring personnel and
purchasing computer hardware and software designed to monitor methamphetamine
precursor purchases;</text>
</paragraph><paragraph changed="added" id="id1548ebd9-d61d-48e2-93a7-ba23604eab61" reported-display-style="italic"><enum>(2)</enum><text>expand existing
methamphetamine precursor or prescription drug monitoring programs to
accomplish the purposes described in subsection (b);</text>
</paragraph><paragraph changed="added" id="id727b6774-cd03-4b9d-be24-1eba53fa3016" reported-display-style="italic"><enum>(3)</enum><text>pay for training and
technical assistance for law enforcement personnel and employees of businesses
that lawfully sell substances, which may be used as methamphetamine
precursors;</text>
</paragraph><paragraph changed="added" id="ideafd5402-0b15-4def-a4f1-7d99309ec403" reported-display-style="italic"><enum>(4)</enum><text>improve information
sharing between adjacent States through enhanced connectivity; or</text>
</paragraph><paragraph changed="added" id="ida84c1459-98bc-4faf-b6da-1117241d93df" reported-display-style="italic"><enum>(5)</enum><text>make grants to
subdivisions of the State to implement methamphetamine precursor monitoring
programs.</text>
</paragraph></subsection><subsection changed="added" id="id533c2306-92f3-4496-9bdd-8ab33ea252ff" reported-display-style="italic"><enum>(d)</enum><header>Application</header><text>Any
State seeking a grant under this section shall submit an application to the
Attorney General at such time, in such manner, and containing such information
as the Attorney General may require.</text>
</subsection><subsection changed="added" commented="no" display-inline="no-display-inline" id="id42a890a9-69f5-4a2f-8912-72ce97f7fe3a" reported-display-style="italic"><enum>(e)</enum><header>Authorization of
appropriations</header><text>There are authorized to be appropriated $5,000,000
for each of the fiscal years 2006 and 2007 to carry out the provisions of this
section.</text>
</subsection></section><section changed="added" id="idc695e525-2051-4110-9677-700f223532ff" reported-display-style="italic"><enum>204.</enum><header>Authorization of
appropriations relating to COPS grants</header>
<subsection changed="added" id="id5ae0c3f5-7577-48d6-9511-22a273c8384d" reported-display-style="italic"><enum>(a)</enum><header>In
general</header><text>In addition to any other funds authorized to be
appropriated for fiscal year 2006 for grants under part Q of title I of the
<act-name parsable-cite="OCCSS">Omnibus Crime Control and Safe Streets Act of
1968</act-name> (<external-xref legal-doc="usc" parsable-cite="usc/42/3796dd">42 U.S.C. 3796dd</external-xref> et seq.),
commonly known as the COPS program, there are authorized to be appropriated
$15,000,000 for such purpose to provide training to State and local prosecutors
and law enforcement agents for the investigation and prosecution of
methamphetamine offenses.</text>
</subsection><subsection changed="added" id="ide74f7df0-cb2d-45b0-b7f9-2fc5a9c5efc9" reported-display-style="italic"><enum>(b)</enum><header>Rural
Set-Aside</header><text>Of amounts made available under subsection (a),
$3,000,000 shall be available only for prosecutors and law enforcement agents
for rural communities.</text>
</subsection></section><section changed="added" id="id51119a0f-d065-4271-a19c-0401fc495e11" reported-display-style="italic"><enum>205.</enum><header>Expansion of
methamphetamine hot spots program to include personnel and equipment for
enforcement, prosecution, and cleanup</header><text display-inline="no-display-inline">Section 1701(d) of the
<act-name parsable-cite="OCCSS">Omnibus Crime Control and Safe Streets Act of
1968</act-name> (<external-xref legal-doc="usc" parsable-cite="usc/42/3796dd(d)">42 U.S.C. 3796dd(d)</external-xref>) is
amended—</text>
<paragraph changed="added" id="id76f2dbb4-957b-4309-b441-a59b155bbf3f" reported-display-style="italic"><enum>(1)</enum><text>in paragraph (11) by
striking <quote>and</quote> at the end;</text>
</paragraph><paragraph changed="added" id="id09a2f657-a620-468b-b0b0-88e5adef93ac" reported-display-style="italic"><enum>(2)</enum><text>in paragraph (12) by
striking the period at the end and inserting <quote>; and</quote>; and</text>
</paragraph><paragraph changed="added" id="idc65a1bf5-b4ec-4127-bcc3-8be987168e21" reported-display-style="italic"><enum>(3)</enum><text>by adding at the end the
following:</text>
<quoted-block changed="added" display-inline="no-display-inline" id="id4099d15d-7fe5-4ba5-b29a-3cba411e997c" reported-display-style="italic" style="OLC">
<paragraph changed="added" commented="no" id="id3a09e209-1433-408a-a03f-85bd57b4ddc9" reported-display-style="italic"><enum>(13)</enum><text>hire personnel and
purchase equipment to assist in the enforcement and prosecution of
methamphetamine offenses and the cleanup of methamphetamine-affected
areas.</text>
</paragraph><after-quoted-block>.</after-quoted-block></quoted-block>
</paragraph></section><section changed="added" commented="no" id="id91bc7315-1ae6-4c26-b314-23b66d81133a" reported-display-style="italic"><enum>206.</enum><header>Special United States
attorneys' program</header>
<subsection changed="added" commented="no" id="ida69b8440-035b-4755-9c16-a8f703119aee" reported-display-style="italic"><enum>(a)</enum><header>In
general</header><text>The Attorney General shall allocate any amounts
appropriated pursuant to the authorization under subsection (c) for the hiring
and training of special assistant United States attorneys.</text>
</subsection><subsection changed="added" commented="no" id="id50678455-1bba-4b49-9135-ba44b166bff6" reported-display-style="italic"><enum>(b)</enum><header>Use of
funds</header><text>The funds allocated under subsection (a) shall be used
to—</text>
<paragraph changed="added" commented="no" id="id54246ba9-7313-4bb2-b75b-ec3d8b5bc0f1" reported-display-style="italic"><enum>(1)</enum><text>train local prosecutors
in techniques used to prosecute methamphetamine cases, including the
presentation of evidence related to the manufacture of methamphetamine;</text>
</paragraph><paragraph changed="added" commented="no" id="id425b7328-995a-4482-80fa-e5ff1150f786" reported-display-style="italic"><enum>(2)</enum><text>train local prosecutors
in Federal and State laws involving methamphetamine manufacture or
distribution;</text>
</paragraph><paragraph changed="added" commented="no" id="id41bb4ed5-a179-42d4-a038-383143225c23" reported-display-style="italic"><enum>(3)</enum><text>cross-designate local
prosecutors as special assistant United States attorneys; and</text>
</paragraph><paragraph changed="added" commented="no" id="id2f04833b-c781-4a94-80d6-9eec4e09d7cd" reported-display-style="italic"><enum>(4)</enum><text>hire additional local
prosecutors who—</text>
<subparagraph changed="added" commented="no" id="idb1dd683b-d9c8-40ae-b704-730717cfb9ec" reported-display-style="italic"><enum>(A)</enum><text>with the approval of the
<inline-comment>United States attorney,</inline-comment> shall be
cross-designated to prosecute both Federal and State methamphetamine
cases;</text>
</subparagraph><subparagraph changed="added" commented="no" id="idb4fb0c32-4fbb-436e-971f-88aa5cdfdc1a" reported-display-style="italic"><enum>(B)</enum><text>shall be assigned a
caseload, whether in State court or Federal court, that gives the highest
priority to cases in which—</text>
<clause changed="added" commented="no" id="iddbeb2fc4-6ea8-4589-9007-112e398bacfb" reported-display-style="italic"><enum>(i)</enum><text>charges related to
methamphetamine manufacture or distribution are submitted by law enforcement
for consideration; and</text>
</clause><clause changed="added" commented="no" id="ida8451011-eea7-4601-9bc7-6ddc53c5e03d" reported-display-style="italic"><enum>(ii)</enum><text>the defendant has been
previously convicted of a crime related to methamphetamine manufacture or
distribution.</text>
</clause></subparagraph></paragraph></subsection><subsection changed="added" commented="no" display-inline="no-display-inline" id="idc023efaa-f552-47de-8338-a84a034d3e84" reported-display-style="italic"><enum>(c)</enum><header>Authorization of
appropriations</header><text>There are authorized to be appropriated $5,000,000
for each of the fiscal years 2006 and 2007 to carry out the provisions of this
section.</text>
</subsection></section>
July 28, 2005
Reported with an amendment